{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:36:42Z","timestamp":1778056602429,"version":"3.51.4"},"reference-count":42,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/or.2012.2077","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T09:37:37Z","timestamp":1349775457000},"page":"125-132","source":"Crossref","is-referenced-by-count":27,"title":["Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay"],"prefix":"10.3892","volume":"29","author":[{"given":"JIAN-HONG","family":"WU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUE-AI","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU-MEI","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENG-SHUANG","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YIN-MEI","family":"DAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"key":"key20180107214646_b1-or-29-01-0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P","article-title":"Estimates of the worldwide incidence of 25 major cancers in 1990","volume":"80","author":"Parkin","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107214646_b2-or-29-01-0125","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107214646_b3-or-29-01-0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"key20180107214646_b4-or-29-01-0125","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180107214646_b5-or-29-01-0125","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"key20180107214646_b6-or-29-01-0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107214646_b7-or-29-01-0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"key20180107214646_b8-or-29-01-0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20180107214646_b9-or-29-01-0125","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ajog.2006.07.036","article-title":"Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less","volume":"195","author":"Pretorius","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107214646_b10-or-29-01-0125","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107214646_b11-or-29-01-0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2007.08.057","article-title":"Evaluation of candidate methylation markers to detect cervical neoplasia","volume":"107","author":"Shivapurkar","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107214646_b12-or-29-01-0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20180107214646_b13-or-29-01-0125","first-page":"199","article-title":"Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression","volume":"22","author":"Iliopoulos","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107214646_b14-or-29-01-0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jnci\/dji041","article-title":"Detection of hypermethylated genes in women with and without cervical neoplasia","volume":"97","author":"Feng","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key20180107214646_b15-or-29-01-0125","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/ijc.22060","article-title":"Assessment of gene promoter hypermethylation for detection of cervical neoplasia","volume":"119","author":"Wisman","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107214646_b16-or-29-01-0125","first-page":"245","article-title":"The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer","volume":"25","author":"Jung","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107214646_b17-or-29-01-0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180107214646_b18-or-29-01-0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/1055-9965.EPI-05-0323","article-title":"Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis","volume":"15","author":"Sova","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107214646_b19-or-29-01-0125","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-07-3194","article-title":"Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107214646_b20-or-29-01-0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-59745-522-0_6","article-title":"The MIRA method for DNA methylation analysis","volume":"507","author":"Rauch","year":"2009","journal-title":"Methods Mol Biol"},{"key":"key20180107214646_b21-or-29-01-0125","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1158\/0008-5472.CAN-05-0064","article-title":"Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer","volume":"65","author":"Martens","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107214646_b22-or-29-01-0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer","volume":"20","author":"Huang","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107214646_b23-or-29-01-0125","first-page":"1741","article-title":"Global DNA methylation in precancerous and cancerous lesions of the uterine cervix","volume":"11","author":"Missaoui","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107214646_b24-or-29-01-0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2008.12.016","article-title":"What will it take to obtain DNA methylation markers for early cervical cancer detection?","volume":"112","author":"Nephew","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20180107214646_b25-or-29-01-0125","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/ijc.24745","article-title":"DNA methylation analysis in liquid-based cytology for cervical cancer screening","volume":"125","author":"Apostolidou","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107214646_b26-or-29-01-0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2009.09.032","article-title":"Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens","volume":"116","author":"Kim","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107214646_b27-or-29-01-0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2010.07.028","article-title":"Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy","volume":"119","author":"Lim","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107214646_b28-or-29-01-0125","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/ijc.26326","article-title":"A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients","volume":"130","author":"Eijsink","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180107214646_b29-or-29-01-0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2010.10.029","article-title":"Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study","volume":"120","author":"Eijsink","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107214646_b30-or-29-01-0125","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1158\/0008-5472.CAN-08-0142","article-title":"Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer","volume":"69","author":"Glockner","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107214646_b31-or-29-01-0125","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.biocel.2007.05.019","article-title":"Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors","volume":"39","author":"Lefebvre","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107214646_b32-or-29-01-0125","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1242\/dev.122.9.2813","article-title":"A male-specific role for SOX9 in vertebrate sex determination","volume":"122","author":"Kent","year":"1996","journal-title":"Development"},{"key":"key20180107214646_b33-or-29-01-0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.10457","article-title":"Molecular profiling of human chondrosarcomas for matrix production and cancer markers","volume":"100","author":"Soderstrom","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180107214646_b34-or-29-01-0125","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1101\/gad.259003","article-title":"The Sox9 transcription factor determines glial fate choice in the developing spinal cord","volume":"17","author":"Stolt","year":"2003","journal-title":"Genes Dev"},{"key":"key20180107214646_b35-or-29-01-0125","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1038\/sj.onc.1205985","article-title":"RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition","volume":"21","author":"Afonja","year":"2002","journal-title":"Oncogene"},{"key":"key20180107214646_b36-or-29-01-0125","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/sj.onc.1207603","article-title":"Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9","volume":"23","author":"Drivdahl","year":"2004","journal-title":"Oncogene"},{"key":"key20180107214646_b37-or-29-01-0125","doi-asserted-by":"crossref","first-page":"e19736","DOI":"10.1371\/journal.pone.0019736","article-title":"Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma","volume":"6","author":"Enjuanes","year":"2011","journal-title":"PLoS One"},{"key":"key20180107214646_b38-or-29-01-0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.bjc.6604143","article-title":"Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays","volume":"98","author":"Aleman","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180107214646_b39-or-29-01-0125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/gcc.20687","article-title":"DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma","volume":"48","author":"Bennett","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180107214646_b40-or-29-01-0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1258\/ebm.2010.010086","article-title":"Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer","volume":"236","author":"Chakravarty","year":"2011","journal-title":"Exp Biol Med"},{"key":"key20180107214646_b41-or-29-01-0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00428-012-1201-7","article-title":"SOX9 expression and its methylation status in gastric cancer","volume":"460","author":"Sun","year":"2012","journal-title":"Virchows Arch"},{"key":"key20180107214646_b42-or-29-01-0125","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1349-7006.2009.01285.x","article-title":"Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings","volume":"100","author":"Wang","year":"2009","journal-title":"Cancer Sci"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2077\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T03:27:15Z","timestamp":1643513235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,10,9]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/or.2012.2077"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2077","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]}}}